We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XELA
13226
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$46K ﹤0.01%
5
+1
+25% +$6.95K
NUWE icon
13227
Nuwellis
NUWE
$477K
0
SUPV
13228
Grupo Supervielle
SUPV
$705M
$45K ﹤0.01%
21,975
-30,782
-58% -$59.9K
TMQ
13229
CALL
Trilogy Metals
TMQ
$646M
$45K ﹤0.01%
18,000
-5,400
-23% -$13.6K
XIN
13230
CALL
DELISTED
Xinyuan Real Estate
XIN
$45K ﹤0.01%
1,690
-1,070
-39% -$27.6K
BNAIW
13231
Brand Engagement Network Warrant
BNAIW
$2.02M
$45K ﹤0.01%
+45,013
New +$37.4K
CSCI
13232
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$45K ﹤0.01%
518
+192
+59% +$18.3K
CNCE
13233
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$45K ﹤0.01%
10,777
-7,613
-41% -$32.2K
GTIM icon
13234
CALL
Good Times Restaurants
GTIM
$16.4M
$44K ﹤0.01%
10,700
-6,100
-36% -$26.5K
HIHO icon
13235
Highway Holdings
HIHO
$4.95M
$44K ﹤0.01%
+11,069
New +$38.9K
TENX icon
13236
Tenax Therapeutics
TENX
$67.4M
$44K ﹤0.01%
13
+3
+30% +$9.51K
VRME icon
13237
VerifyMe
VRME
$8.66M
$44K ﹤0.01%
10,460
-7,799
-43% -$30.3K
GHSI
13238
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$44K ﹤0.01%
504
-550
-52% -$47.8K
BIMI
13239
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$44K ﹤0.01%
652
-2,586
-80% -$180K
ACGN
13240
PUT
DELISTED
Aceragen Inc
ACGN
$44K ﹤0.01%
2,137
-7,714
-78% -$155K
KIQ
13241
DELISTED
Kelso Technologies Inc.
KIQ
$44K ﹤0.01%
64,392
+31,868
+98% +$23.6K
ARMP icon
13242
Armata Pharmaceuticals
ARMP
$167M
$43K ﹤0.01%
10,873
-10,433
-49% -$43.9K
FTEK icon
13243
PUT
Fuel Tech
FTEK
$45.3M
$43K ﹤0.01%
18,500
+2,700
+17% +$6.28K
INDP icon
13244
Indaptus Therapeutics
INDP
$143M
$43K ﹤0.01%
110
-90
-45% -$39.6K
PHIO icon
13245
PUT
Phio Pharmaceuticals
PHIO
$12.7M
$43K ﹤0.01%
+175
New +$43.1K
PVL
13246
CALL
Permianville Royalty Trust
PVL
$58.1M
$43K ﹤0.01%
22,100
+1,200
+6% +$1.98K
TOMZ icon
13247
TOMI Environmental Solutions
TOMZ
$13.5M
$43K ﹤0.01%
4,945
+1,012
+26% +$9.57K
XELB icon
13248
Xcel Brands
XELB
$5.69M
$43K ﹤0.01%
1,430
-1,443
-50% -$31.4K
XYLO
13249
DELISTED
Xylo Technologies
XYLO
$43K ﹤0.01%
595
-1,802
-75% -$131K
VCNX
13250
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$43K ﹤0.01%
74
-230
-76% -$122K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.